Search bioRxiv⌕ Search

bioRxiv · 10.64898/2025.12.19.695357

COPS5 is Essential for Sertoli Cell Function and Male Fertility in Mice

Abstract

The COP9 signalosome subunit 5 (COPS5) is a multifunctional protein that regulates ubiquitin-dependent processes. Global knockout of Cops5 is embryonically lethal, and while it is known to be vital in germ cells and testicular smooth muscle, its function in Sertoli cells, the key somatic supporters of spermatogenesis, remains entirely unknown. This study investigates the critical role of COPS5 within Sertoli cells. Using Sertoli cell-specific Cops5 knockout mouse models, we demonstrate that COPS5 is essential for maintaining male fertility. Sertoli-specific Cops5 ablation resulted in age-dependent male infertility, despite normal initial development. Mutants exhibited progressive testicular atrophy, oligoasthenospermia, and significantly reduced testis weight. Histology showed vacuolated, disorganized tubules devoid of germ cells and sperm. Crucially, COPS5 loss disrupted Sertoli cell polarity, evidenced by aberrant cytoplasmic mislocalization of the nuclear marker WT1 and detachment from the basement membrane. Integrity of the blood-testis barrier (BTB) was severely compromised, with discontinuous and punctate expression of the tight junction adaptor ZO-1. Intercellular communication was also impaired, shown by a stark reduction in Connexin 43 gap junction signals. Our findings establish that COPS5 is an indispensable intrinsic regulator of Sertoli cell function. Its loss disrupts cell polarity, BTB architecture, and gap junction communication, leading to failed support of spermatogenesis and consequently infertility. This work defines a novel and critical somatic function for COPS5 in male reproduction. We conclude that COPS5 is intrinsically required in Sertoli cells to maintain their polarity and BTB function, which are foundational for supporting germ cell development and ensuring male fertility. This identifies COPS5 as a novel, essential regulator within the testicular somatic compartment.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Niu, C., Li, T., Li, W., Yap, Y. T., Huang, Q., Jiang, L., Dhikhirullahi, O., Miciuda, A., Faddoul, E., Song, S., Griswold, M. D., Zhang, Z.. 2025-12-22. COPS5 is Essential for Sertoli Cell Function and Male Fertility in Mice. https://doi.org/10.64898/2025.12.19.695357

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

OPA1 controls mitochondrial dysfunction-driven liver fibrosis in MASLD

Progressive hepatic fibrosis is the principal determinant of morbidity and mortality in metabolic dysfunction-associated steatotic liver disease and steatohepatitis (MASLD/MASH). Mitochondrial dysfunction is a hallmark of MASH, and the release of mitochondrial damage-associated molecular patterns (mito-DAMPs) from injured hepatocytes can promote fibrosis. However, how mitochondrial dynamics and quality control shape the fibrotic response in MASLD/MASH remains unclear. Here, through large-scale genomic analyses of mitochondrial genes governing mitophagy, fusion and fission in human MASLD, with a power-equivalent sample size of approximately 700,000 individuals, we identify a strong association between hepatic fibrosis and the mitochondrial fusion factor dynamin-like GTPase optic atrophy 1 (OPA1). OPA1 transcripts and protein abundance in the liver epithelium were progressively dysregulated with advancing fibrosis. In mice, hepatocyte-specific OPA1 loss alone was sufficient to induce hepatic stellate cell activation and fibrosis in zone 3, promoted the release of mito-DAMPs into the circulation and exacerbated fibrosis in experimental MASH. These findings identify OPA1 as a central regulator of the hepatic fibrotic response and connect defective mitochondrial homeostasis to mito-DAMP release, hepatic stellate cell activation and fibrosis in MASLD.

genetics↗

Temporal control of mitochondrial mutagenesis reveals the fate of mtDNA mutations with age

Mutations in the mitochondrial genome (mtDNA) play a critical role in the aging process and a wide variety of age-related diseases. However, it remains unclear when the mutations that drive physiological decline arise. To answer this question, we generated a new mouse model in which mitochondrial mutagenesis can be confined to a defined window of time. Surprisingly, we found that mutations that arise during the first two months of life are sufficient to drive a wide variety of age-related pathologies, and that the severity of this pathology is broadly regulated by distinct, tissue-specific selective pressures that control the fate of mtDNA mutations with age. Further, we found that selection against deleterious variants can be modulated by manipulation of mitochondrial fusion in vitro and in vivo. These observations raise the possibility that in some tissues, the pace of aging is pre-determined by events that occur early in life and that interventions targeting mitochondrial fusion may be able to slow down or reverse the expansion of these pathogenic variants. These results carry far-reaching implications for strategies aimed at preventing or delaying age-related decline.

genetics↗

Innate immune stress pathway activation underlies heterochromatin dysfunction pathology

Heterochromatin loss disrupts nuclear architecture, gene regulation and repetitive element silencing, and is associated with diverse human diseases. However, mechanisms linking heterochromatin dysfunction to pathological phenotypes remain unclear. Using genetic interaction screening and genomic analyses in C. elegans, we identify secondary activation of the Intracellular Pathogen Response (IPR), an innate immune stress pathway, as a major contributor to heterochromatin mutant phenotypes. Constitutive IPR activation phenocopies slow growth and indirect transcriptional changes observed in these mutants. Depletion of genetic enhancers further increased, whereas suppressor RNAi attenuated IPR activation, with direct heterochromatin targets remaining substantially deregulated. Notably, many suppressors encode active chromatin components, and mild reduction of RNA polymerase II activity ameliorates growth defects in C. elegans HP1 mutants and human HP1-deficient cells. Our findings reveal secondary stress response activation as an important mechanism linking heterochromatin dysfunction to pathology and identify transcriptional dampening as a potential therapeutic strategy for mitigating these effects.

genetics↗